#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Vulval cancer Cutaneous lupus erythematosus Soft tissue sarcoma Primary adrenal insufficiency Follicle centre lymphoma follicular grade I, II – III Prader-Willi syndrome Anaplastic thyroid cancer Lennox-Gastaut syndrome Cholestatic pruritus Orthostatic hypotension Exudative retinopathy Gastrointestinal stromal tumour Penile squamous cell carcinoma Rectal cancer Angiosarcoma recurrent More trials…

    Learn about Rare Diseases

    Pulmonary fibrosis – Life with Disease Hepatoblastoma – Life with Disease MELAS syndrome – Diagnostics Glomerulonephritis membranoproliferative – Treatment Urea cycle disorder – Diagnostics Primary hyperoxaluria – Diagnostics Phenylketonuria – Trials in Disease Aicardi-Goutieres syndrome – Trials in Disease Ornithine transcarbamoylase deficiency – Diagnostics Pleural mesothelioma malignant – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Posdinemab Nystatin Clomipramine Hydrochloride ORG-129 LTI-03 Hydrocortisone Hemisuccinate Umeclidinium Vindesine Sulfate Tipranavir Alpha1H Vatiquinone Troriluzole Azd5462 Pyridoxine Hydrochloride Peposertib Levamlodipine Succinate Travoprost Propafenone Hydrochloride Atenolol Risperidone More therapies…

    Learn about Your Condition

    Chondrosarcoma metastatic Oropharyngeal cancer recurrent Adenosquamous cell lung cancer Cerebral palsy Angelman's syndrome Pouchitis Vascular calcification Cushing's syndrome Cryoglobulinaemia Thrombocytosis Hypochromic anaemia Congenital pseudarthrosis Urinary incontinence Pulmonary congestion Chorioretinitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Acute leukaemia

  • A study of Enzomenib in adult patients with relapsed or refractory acute leukemia, including those with MLL rearrangement or NPM1 mutation.

    Recruiting

    2 1 1
    Investigated Diseases:
    • Acute leukaemia
    Belgium France Italy Spain

  • A Study Testing Bleximenib in People with Acute Leukemia

    Recruiting

    1 1 1
    Investigated Diseases:
    • Acute leukaemia
    Investigated Drugs:
    • BLEXIMENIB
    • JNJ-75276617
    Belgium France The Netherlands Spain

  • Study on the Safety and Tolerability of SNDX-5613 for Patients with Relapsed or Refractory Acute Leukemias

    Recruiting

    2 1 1
    Investigated Drugs:
    • N-Ethyl-2-[4-[7-[[4-(Ethylsulfonylamino)Cyclohexyl]Methyl]-2,7-Diazaspiro[3.5]Nonan-2-Yl]Pyrimidin-5-Yl]Oxy-5-Fluoro-N-Propan-2-Ylbenzamide
    • Revumenib
    France Germany Italy Lithuania The Netherlands Spain

  • Study on Ponatinib for Treating Recurrent or Refractory Leukemias and Solid Tumors in Children

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Myeloid leukaemia
    • Acute leukaemia
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Ponatinib
    Belgium France Italy The Netherlands Spain Sweden

  • Study Comparing Fosfomycin and Ciprofloxacin for Preventing Fever in Patients with Acute Leukemia After Chemotherapy or Stem Cell Transplant

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Autologous haematopoietic stem cell transplant
    • Allogenic stem cell transplantation
    • Acute leukaemia
    Investigated Drugs:
    • FOSFOMYCIN CALCIUM
    • Ciprofloxacin Hydrochloride
    • Ciprofloxacin
    Spain

  • Study on Triptorelin for Fertility Protection in Young Women and Teenagers Undergoing Chemotherapy for Breast Cancer, Leukemia, Lymphomas, and Sarcomas

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Osteosarcoma
    • Soft tissue sarcoma
    • Ewing’s sarcoma
    Investigated Drugs:
    • Triptorelin
    Sweden
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!